Overdiagnosis of bladder carcinoma

Analytical and Quantitative Cytology and Histology

Volumn 30, Issue 5, 2008, Pages 261-264

  Cheng, Liang ^a   Bostwick, David G ^b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BOSTWICK LABORATORIES   (United States)

Author keywords

Bladder cancer; Overdiagnosis; Urinary bladder

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; CANCER DIAGNOSIS; CANCER PATIENT; CANCER SURGERY; CARCINOMA IN SITU; CLINICAL ARTICLE; CYSTITIS; DIAGNOSTIC ERROR; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HYPERPLASIA; INVERTED PAPILLOMA; MALE; MEDICAL RECORD REVIEW; PAPILLOMA; PATIENT IDENTIFICATION; PRIORITY JOURNAL; TRANSITIONAL CELL CARCINOMA; TRANSURETHRAL RESECTION; UROGENITAL TRACT CANCER; UROGENITAL TRACT TUMOR; BLADDER TUMOR; MIDDLE AGED; RETROSPECTIVE STUDY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, TRANSITIONAL CELL; CYSTITIS; DIAGNOSTIC ERRORS; HUMANS; HYPERPLASIA; MIDDLE AGED; PAPILLOMA; RETROSPECTIVE STUDIES; URINARY BLADDER NEOPLASMS;

EID: 58149161242     PISSN: 08846812     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Bol MG, Baak JP, Buhr-Wildhagen S, Kruse AJ, Kjellevold KH, Janssen EA, Mestad O, Ogreid P: Reproducibility and prognostic variability of grade and lamina propria invasion in stages Ta, T1 urothelial carcinoma of the bladder. J Urol 2003;169:1291-1294 (Pubitemid 36323769)
2. Coblentz TR, Mills SE, Theodorescu D: Impact of second opinion pathology in the definitive management of patients with bladder carcinoma. Cancer 2001;91:1284-1290 (Pubitemid 32267039)
3. Jones TD, Cheng L: Papillary urothelial neoplasm of low malignant potential: Evolving terminology and concepts. J Urol 2006;175:1995-2003
4. Mikuz G: The reliability and reproducibility of the different classifications of bladder cancer. In Surgical Pathology Update 2001. Edited by S Haupmann, M Dietel, M Sorbrinho-Simoes. Berlin, ABW-Wissenschaftsverlag, 2001, pp 114-115
5. Murphy WM, Takezawa K, Maruniak NA: Interobserver discrepancy using the 1998 World Health Organization/International Society of Urologic Pathology classification of urothelial neoplasms: Practical choices for patient care. J Urol 2002;168:968-972
6. Yorukoglu K, Tuna B, Dikicioglu E, Duzcan E, Isisag A, Sen S, Mungan U, Kirkali Z: Reproducibility of the 1998 World Health Organization/International Society of Urologic Pathology classification of papillary urothelial neoplasms of the urinary bladder. Virchows Arch 2003;443:734-740
7. Maclennan GT, Kirkali Z, Cheng L: Histologic grading of noninvasive papillary urothelial neoplasms. Eur Urol 2007;51:889-898 (Pubitemid 46281427)
8. Cheng L, Lopez-Beltran A, MacLennan GT, Montironi R, Bostwick DG: Neoplasms of the urinary bladder. In Urologic Surgical Pathology. Second edition. Edited by DG Bostwick, L Cheng. Philadelphia, Elsevier/Mosby, 2008, pp 259-352
9. Lopez-Beltran A, Cheng L: Histologic variants of urothelial carcinoma: Differential diagnosis and clinical implications. Hum Pathol 2006;37:1371-1388 (Pubitemid 44584326)
10. Sung MT, Maclennan GT, Lopez-Beltran A, Montironi R, Cheng L: Natural history of urothelial inverted papilloma. Cancer 2006;107:2622-2627 (Pubitemid 44845617)
11. Jones TD, Zhang S, Lopez-Beltran A, Eble JN, Sung MT, MacLennan GT, Montironi R, Tan PH, Zheng S, Baldridge LA, Cheng L: Urothelial carcinoma with an inverted growth pattern can be distinguished from inverted papilloma by fluorescence in-situ hybridization, immunohistochemistry, and morphologic analysis. Am J Surg Pathol 2007;31:1861-1867 (Pubitemid 350175813)
12. Bostwick DG, Ramnani DM, Cheng L: Diagnosis and grading of bladder cancer and associated lesions. Urol Clin North Am 1999;26:493-507 (Pubitemid 29411681)
13. Montironi R, Lopez-Beltran A, Mazzuchelli R, Bostwick DG: Classification and grading of the non-invasive neoplasms: Recent advances and controversies. J Clin Pathol 2003;56:91-95 (Pubitemid 36177249)
14. Montironi R, Mazzucchelli R, Scarpelli M, Lopez-Beltran A, Cheng L: Morphological diagnosis of urothelial neoplasms. J Clin Pathol 2008;61:3-10
15. Eble JN, Sauter G, Epstein JI, Sesterhenn IAE: World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs. Lyon, IARC Press, 2004
16. Young RH: Papillary and polypoid cystitis: A report of eight cases. Am J Surg Pathol 1988;12:542-546 (Pubitemid 18164620)
17. Young RH: Pseudoneoplastic lesions of the urinary bladder. Pathology Annu 1988;23:67-104
18. Young RH, Clement PB: Mullerianosis of the urinary bladder. Mod Pathol 1996;9:731-737
19. Young RH, Scully RE: Nephrogenic adenoma: A report of 15 cases, review of the literature, and comparison with clear cell adenocarcinoma of the urinary tract. Am J Surg Pathol 1986;10:268-275 (Pubitemid 16069392)
20. Eble JN, Young RH: Benign and low-grade papillary lesions of the urinary bladder: A review of the papilloma-papillary carcinoma controversy, and a report of five typical papillomas. Semin Diagn Pathol 1989;6:351-371
21. Montironi R, Lopez-Beltran A: The 2004 WHO classification of bladder tumors: A summary and commentary. Int J Surg Pathol 2005;13:143-153
22. Renshaw AA: Comparing methods to measure error in gynecologic cytology and surgical pathology. Arch Pathol Lab Med 2006;130:626-629
23. Lopez-Beltran A: Urothelial changes induced by therapeutic procedures for bladder cancer. Anal Quant Cytol Histol 2006;28:339
24. Mazzucchelli R, Tuna B: Noninvasive urothelial neoplasms: Which classification? Anal Quant Cytol Histol 2006;28:340
25. Bhatia A, Dey P, Kumar Y: Morphometry of urinary atypical cells. Anal Quant Cytol Histol 2007;29:183-184
26. Chadwick B, Willmore-Payne C, Holden J, Layfield L: Fluorescence in situ hybridization determination of aneusomy: Criteria and technical considerations. Anal Quant Cytol Histol 2007;29:351-357 (Pubitemid 350304992)
27. Lopez-Beltran A: Immunohistochemical markers in evaluation of urinary and bladder tumors. Anal Quant Cytol Histol 2007;29:121-122 (Pubitemid 46649490)
28. Lopez-Beltran A, Maclennan GT, de la Haba-Rodriguez J, Montironi R, Cheng L: Research advances in apoptosis-mediated cancer therapy: A review. Anal Quant Cytol Histol 2007;29:71-78 (Pubitemid 46649484)
29. Martignoni G, Brunelli M, Gobbo S, Remo A, Ficarra V, Cossu-Rocca P, Pea M, Chilosi M, Menestrina F, Cheng L: Role of molecular markers in diagnosis and prognosis of renal cell carcinoma. Anal Quant Cytol Histol 2007;29:41-49 (Pubitemid 46333520)
30. Nafe R, Glienke W, Hattingen E, Schlote W, Lanfermann H, Zanella F: Correlation between amplification of the gene for the epidermal growth factor receptor (EGFR), data from preoperative proton-MR-spectroscopy (1HMRS) and histomorphometric data of glioblastomas. Anal Quant Cytol Histol 2007;29:199-207 (Pubitemid 47311327)
31. Ondracek RP, Parker F, Allen A, Davis W, Ray M, McCann W, Marshall JR: Standardization of nuclear morphometry-based biomarkers. Anal Quant Cytol Histol 2007;29:309-316
32. Vidal-Jimenez A: New immunohistochemical markers in testicular tumors. Anal Quant Cytol Histol 2007;29:377
33. Requena MJ, Alvarez-Kindelan J, Blanca A: Immunohistochemical markers in the evaluation of tumors of the urinary bladder: A review. Anal Quant Cytol Histol 2007;29:380-382 (Pubitemid 350304999)
34. Yang Y, Zhang L, Wei Y, Wang H, Xiong W, Chen Z, Hes O, Zheng J: Detection of EWSR1 translocation with nuclear extraction-based fluorescence in situ hybridization for diagnosis of Ewing's sarcoma/primitive neuroectodermal tumor. Anal Quant Cytol Histol 2007;29:221-230 (Pubitemid 47311330)
35. Jones TD, Carr MD, Eble JN, Wang M, Lopez-Beltran A, Cheng L: Clonal origin of lymph node metastases in bladder carcinoma. Cancer 2005;104:1901-1910 (Pubitemid 41513173)
36. Jones TD, Wang M, Eble JN, MacLennan GT, Lopez-Beltran A, Zhang S, Cocco A, Cheng L: Molecular evidence supporting field effect in urothelial carcinogenesis. Clin Cancer Res 2005;11:6512-6519 (Pubitemid 41338989)
37. Sung MT, Zhang S, MacLennan GT, Lopez-Beltran A, Montironi R, Wang M, Tan PH, Cheng L: Histogenesis of clear cell adenocarcinoma in the urinary tract: Evidence of urothelial origin. Clin Cancer Res 2008;14:1947-1955 (Pubitemid 351551103)
38. Sung MT, Lopez-Beltran A, Eble JN, MacLennan GT, Tan PH, Montironi R, Jones TD, Ulbright TM, Blair JE, Cheng L: Divergent pathway of intestinal metaplasia and cystitis glandularis of the urinary bladder. Mod Pathol 2006;19:1395-1401 (Pubitemid 44624156)
39. Lott S, Lopez-Beltran A, MacLennan GT, Montironi R, Cheng L: Soft tissue tumors of the urinary bladder: Part I. Myofibroblastic proliferations, benign neoplasms, and tumors of uncertain malignant potential. Hum Pathol 2007;38:807-823
40. Lott S, Lopez-Beltran A, Montironi R, MacLennan GT, Cheng L: Soft tissue tumors of the urinary bladder: Part II. Malignant neoplasms. Hum Pathol 2007;38:807-823
41. Morton MJ, Zhang S, Lopez-Beltran S, MacLennan GT, Eble JN, Montironi R, Sung MT, Tan PH, Zheng S, Zhou H, Cheng L: Telomere shortening and chromosomal abnormalities in intestinal metaplasia of the urinary bladder. Clin Cancer Res 2007;13:6232-6236 (Pubitemid 350075085)
42. Cheng L, Neumann RM, Weaver AL, Spotts BE, Bostwick DG: Predicting cancer progression in patients with stage T1 bladder carcinoma. J Clin Oncol 1999;17:3182-3187 (Pubitemid 29470649)
43. Cheng L, Neumann RM, Nehra A, Spotts BE, Weaver AL, Bostwick DG: Cancer heterogeneity and its biologic implications in the grading of urothelial carcinoma. Cancer 2000;88:1663-1670 (Pubitemid 30183152)
44. Cheng L, Pan CX, Yang XJ, Lopez-Beltran A, MacLennan GT, Lin H, Kuzel TM, Papavero V, Tretiakova M, Nigro K, Koch MO, Eble JN: Small cell carcinoma of the urinary bladder: A clinicopathologic analysis of 64 patients. Cancer 2004;101:957-962 (Pubitemid 39100428)
45. Cheng L, Neumann RM, Bostwick DG: Papillary urothelial neoplasms of low malignant potential: Clinical and biologic implications. Cancer 1999;86:2102-2108
46. Cheng L, Jones TD, McCarthy RP, Eble JN, Wang M, MacLennan GT, Lopez-Beltran A, Yang XJ, Kock MO, Zhang S, Pan CX, Baldridge LA: Molecular genetic evidence for a common clonal origin of urinary bladder small cell carcinoma and coexisting urothelial carcinoma. Am J Pathol 2005;166:1533-1539 (Pubitemid 40586521)
47. Cheng L, Cheville JC, Sebo TJ, Eble JN, Bostwick DG: Atypical nephrogenic metaplasia of the urinary tract: A precursor lesion? Cancer 2000;88:853-861
48. Cheng L, Cheville JC, Neumann RM, Bostwick DG: Flat intraepithelial lesions of the urinary bladder. Cancer 2000;88:625-631 (Pubitemid 30056939)
49. Cheng L, Cheville JC, Neumann RM, Bostwick DG: Natural history of urothelial dysplasia of the bladder. Am J Surg Pathol 1999;23:443-447 (Pubitemid 29160005)
50. Cheng L, Bostwick DG, Li G, Zhang S, Vortmeyer AO, Zhuang Z: Conserved genetic findings in metastatic bladder cancer: A possible utility of allelic loss of chromosomes 9p21 and 17p13 in diagnosis. Arch Pathol Lab Med 2001;125:1197-1199 (Pubitemid 32845796)
51. Cheng L, Gu J, Ulbright TM, MacLennan GT, Sweeney CJ, Zhang S, Sanchez K, Kock MO, Eble JN: Precise microdissection of human bladder carcinomas reveals divergent tumor subclones in the same tumor. Cancer 2002;94:104-110 (Pubitemid 34049047)
52. Cheng L, MacLennan GT, Pan CX, Jones TD, Moore CR, Zhang S, Gu J, Patel NB, Kao C, Gardner TA: Allelic loss of the active X chromosome during bladder carcinogenesis. Arch Pathol Lab Med 2004;128:187-190 (Pubitemid 38155665)
53. Cheng L, MacLennan GT, Zhang S, Wang M, Pan CX, Koch MO: Laser capture microdissection analysis reveals frequent allelic losses in papillary urothelial neoplasm of low malignant potential of the urinary bladder. Cancer 2004;101:183-188 (Pubitemid 38812439)